Mendelian randomization implies no direct causal association between leukocyte telomere length and amyotrophic lateral sclerosis
Yixin Gao(Sun Yat-sen University), Pietro Pietrini(IMT School for Advanced Studies Lucca), Lauren Bartley(Neuroscience Research Australia), David Mann(University of Manchester), John B. Kwok(UNSW Sydney), Ting Wang(Xuzhou Medical College), Agustı́n Ruiz(Biomedical Research Networking Center on Neurodegenerative Diseases), Christer Nilsson(Swedish University of Agricultural Sciences), Peter R. Schofield(UNSW Sydney), Xinghao Yu(Soochow University), Elio Scarpini(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), María Serpente(University of Milan), Alan Thomas(Cleveland Clinic), Jordi Clarimón(Universitat Autònoma de Barcelona), Luisa Benussi(Centro San Giovanni di Dio Fatebenefratelli), Carlos Cruchaga(Washington University in St. Louis), Eric Haan(The University of Adelaide), William S. Brooks(UNSW Sydney), Carol Dobson‐Stone(Neuroscience Research Australia), Glenda M. Halliday(The University of Sydney), Adaikalavan Ramasamy(King's College London), Merçé Boada(Instituto de Salud Carlos III), Ian R. Mackenzie(University of British Columbia), Jordan Grafman(Northwestern University), Olivier Piguet(The University of Sydney), Ging‐Yuek Robin Hsiung(University of British Columbia), Giuliano Binetti(Centro San Giovanni di Dio Fatebenefratelli), Elizabeth Thompson, Roberta Ghidoni(Centro San Giovanni di Dio Fatebenefratelli), Timothy D. Griffiths(Queen Mary University of London), Jonathan D. Rohrer(University Memory and Aging Center), Nigel J. Cairns(Washington University in St. Louis), Chiara Fenoglio(University of Milan), Johannes Attems(Newcastle University), Christopher M. Morris(NIHR Newcastle Biomedical Research Centre), Daniela Galimberti(University of Milan), Gianluigi Forloni(Mario Negri Institute for Pharmacological Research), Alessandro Padovani(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Barbara Borroni(Centro San Giovanni di Dio Fatebenefratelli), Rafael Blesa(Universitat Autònoma de Barcelona), Maria Landqvist Waldö(Lund University), Diego Albani(Mario Negri Institute for Pharmacological Research), John R. Hodges(Neuroscience Research Australia), Dena Hernandez(National Institutes of Health), Raffaele Ferrari(University College London), Michael A. Nalls(Institute on Aging), Isabel Hernández(Fundació ACE), Karin Nilsson(Sahlgrenska University Hospital), Alberto Lleó(Universitat Autònoma de Barcelona), Ian G. McKeith(Newcastle Hospitals - Campus for Ageing and Vitality)
Cited by 10
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
|Alzheimer s & Dementia|2012|3.2k